The biophysical properties of TRIC-A and TRIC-B and their interactions with RyR2.
Hu J. et al, (2023), J Gen Physiol, 155
Integrated Proteomics Unveils Nuclear PDE3A2 as a Regulator of Cardiac Myocyte Hypertrophy.
Subramaniam G. et al, (2023), Circ Res
Biophysical characteristics of TRIC-A and TRIC-B channels and their regulation of RYR2.
Hu J. et al, (2022), J Gen Physiol, 154
The V2475F CPVT1 mutation yields distinct RyR2 channel populations that differ in their responses to cytosolic Ca2+ and Mg2.
Wilson AD. et al, (2021), J Physiol, 599, 5179 - 5201
A Homology Modelling Study of Potential RyR2 Structural Changes in R2474S and V2475F CPVT1
Hu J. et al, (2021), BIOPHYSICAL JOURNAL, 120, 150A - 150A
Development of an enzyme-linked immunosorbent assay for Keap1-Nrf2 interaction inhibitors identification.
Wang Y. et al, (2020), Redox Biol, 34
Design, synthesis, and biological activity of a novel series of benzofuran derivatives against oestrogen receptor-dependent breast cancer cell lines.
Jin L-P. et al, (2020), Bioorg Chem, 95
Synthesis and biological evaluation of indole-3-carboxamide derivatives as antioxidant agents
Huang E. et al, (2019), Chinese Chemical Letters, 30, 2157 - 2159
Synthesis, β -catenin Translocation Capability and ALP Activation Activity of 7H-thiazolo[3,2-b]-1,2,4-triazin-7-one Derivatives.
Hou S. et al, (2018), Med Chem, 14, 67 - 73
Discovery of a Novel HIV-1 Integrase/p75 Interacting Inhibitor by Docking Screening, Biochemical Assay, and in Vitro Studies.
Wang Y. et al, (2017), J Chem Inf Model, 57, 2336 - 2343
Herbalog: A tool for target-based identification of herbal drug efficacy through molecular docking.
Wang Y. et al, (2016), Phytomedicine, 23, 1469 - 1474
Using molecular docking screening for identifying hyperoside as an inhibitor of fatty acid binding protein 4 from a natural product database
Wang Y. et al, (2016), Journal of Functional Foods, 20, 159 - 170
Pimozide, a novel fatty acid binding protein 4 inhibitor, promotes adipogenesis of 3T3-L1 cells by activating PPARγ.
Wang Y. et al, (2015), ACS Chem Neurosci, 6, 211 - 218
Identification of 1, 4-Dihydrothieno [3', 2':5, 6]thiopyrano[4, 3-c] pyrazole derivatives as human 5-Lipo-oxygenase inhibitors.
Hu J. et al, (2014), Chem Biol Drug Des, 84, 642 - 647
Discovery of FDA-approved drugs as inhibitors of fatty acid binding protein 4 using molecular docking screening.
Wang Y. et al, (2014), Journal of chemical information and modeling, 54, 3046 - 3050
Silibinin, a novel chemokine receptor type 4 antagonist, inhibits chemokine ligand 12-induced migration in breast cancer cells.
Wang Y. et al, (2014), Phytomedicine, 21, 1310 - 1317